JP2024542995A5 - - Google Patents
Info
- Publication number
- JP2024542995A5 JP2024542995A5 JP2024525233A JP2024525233A JP2024542995A5 JP 2024542995 A5 JP2024542995 A5 JP 2024542995A5 JP 2024525233 A JP2024525233 A JP 2024525233A JP 2024525233 A JP2024525233 A JP 2024525233A JP 2024542995 A5 JP2024542995 A5 JP 2024542995A5
- Authority
- JP
- Japan
- Prior art keywords
- inventions
- polynucleotide
- sequence
- polynucleotide according
- nucleotides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275425P | 2021-11-03 | 2021-11-03 | |
| US63/275,425 | 2021-11-03 | ||
| US202263352158P | 2022-06-14 | 2022-06-14 | |
| US63/352,158 | 2022-06-14 | ||
| PCT/US2022/079124 WO2023081689A2 (en) | 2021-11-03 | 2022-11-02 | Polynucleotides, compositions, and methods for genome editing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542995A JP2024542995A (ja) | 2024-11-19 |
| JP2024542995A5 true JP2024542995A5 (enExample) | 2025-11-12 |
Family
ID=84537879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525233A Pending JP2024542995A (ja) | 2021-11-03 | 2022-11-02 | ゲノム編集のためのポリヌクレオチド、組成物、及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240301377A1 (enExample) |
| EP (1) | EP4426822A2 (enExample) |
| JP (1) | JP2024542995A (enExample) |
| KR (1) | KR20240114296A (enExample) |
| AU (1) | AU2022382975A1 (enExample) |
| CA (1) | CA3237303A1 (enExample) |
| CL (1) | CL2024001332A1 (enExample) |
| CO (1) | CO2024007019A2 (enExample) |
| IL (1) | IL312508A (enExample) |
| MX (1) | MX2024005242A (enExample) |
| TW (1) | TW202325848A (enExample) |
| WO (1) | WO2023081689A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115516773A (zh) * | 2020-05-08 | 2022-12-23 | 瑞典爱立信有限公司 | 多功能aas接收机 |
| WO2021228349A1 (en) | 2020-05-11 | 2021-11-18 | Telefonaktiebolaget Lm Ericsson (Publ) | Efficient prach scheduling |
| WO2025081064A2 (en) * | 2023-10-11 | 2025-04-17 | Illumina, Inc. | Thermophilic deaminase and methods for identifying modified cytosine |
| WO2025137301A1 (en) * | 2023-12-20 | 2025-06-26 | Intellia Therapeutics, Inc. | Methods for rapid engineering of cells |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585481A (en) | 1987-09-21 | 1996-12-17 | Gen-Probe Incorporated | Linking reagents for nucleotide probes |
| US5378825A (en) | 1990-07-27 | 1995-01-03 | Isis Pharmaceuticals, Inc. | Backbone modified oligonucleotide analogs |
| JP3131222B2 (ja) | 1991-12-24 | 2001-01-31 | アイシス・ファーマシューティカルス・インコーポレーテッド | ギャップを有する２′修飾オリゴヌクレオチド |
| JPH10500310A (ja) | 1994-05-19 | 1998-01-13 | ダコ アクティーゼルスカブ | 淋菌及びトラコーマ クラミジアの検出のためのｐｎａ プローブ |
| US20060051405A1 (en) | 2004-07-19 | 2006-03-09 | Protiva Biotherapeutics, Inc. | Compositions for the delivery of therapeutic agents and uses thereof |
| DK2931891T3 (da) | 2012-12-17 | 2019-08-19 | Harvard College | Rna-styret modificering af menneskelige genomer |
| CN107879960B (zh) | 2013-03-08 | 2021-06-22 | 诺华股份有限公司 | 用于传递活性成分的脂质和脂质组合物 |
| CN112301024A (zh) | 2013-03-15 | 2021-02-02 | 通用医疗公司 | 使用RNA引导的FokI核酸酶(RFN)提高RNA引导的基因组编辑的特异性 |
| US20150165054A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| EP3083556B1 (en) | 2013-12-19 | 2019-12-25 | Novartis AG | Lipids and lipid compositions for the delivery of active agents |
| CN106794141B (zh) | 2014-07-16 | 2021-05-28 | 诺华股份有限公司 | 将核酸包封在脂质纳米粒主体中的方法 |
| CN120842296A (zh) | 2015-09-21 | 2025-10-28 | 垂林克生物技术有限公司 | 用于合成5’-加帽rna的组合物和方法 |
| LT3436077T (lt) | 2016-03-30 | 2025-06-25 | Intellia Therapeutics, Inc. | Lipidų nanodalelių vaisto formos, skirtos crispr/cas komponentams |
| WO2018067447A1 (en) | 2016-10-03 | 2018-04-12 | Itellia Therapeutics, Inc. | Improved methods for identifying double strand break sites |
| KR20240116572A (ko) * | 2017-03-23 | 2024-07-29 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제 |
| WO2019067910A1 (en) | 2017-09-29 | 2019-04-04 | Intellia Therapeutics, Inc. | POLYNUCLEOTIDES, COMPOSITIONS AND METHODS FOR GENOMIC EDITION |
| US20230140670A1 (en) | 2017-09-29 | 2023-05-04 | Intellia Therapeutics, Inc. | Formulations |
| IL317505A (en) | 2017-11-10 | 2025-02-01 | Univ Massachusetts | CRISPR-directed delivery platforms |
| WO2020051562A2 (en) * | 2018-09-07 | 2020-03-12 | Beam Therapeutics Inc. | Compositions and methods for improving base editing |
| US20220009878A1 (en) | 2018-10-02 | 2022-01-13 | Intellia Therapeutics, Inc. | Ionizable amine lipids |
| IL282267B2 (en) * | 2018-10-15 | 2026-03-01 | Univ Massachusetts | Programmed DNA editing by chimeric deaminase-nme2cas9 proteins |
| BR112021010853A2 (pt) | 2018-12-05 | 2021-08-31 | Intellia Therapeutics, Inc. | Lipídios de amina modificados |
| MX2021011757A (es) | 2019-03-28 | 2021-12-10 | Intellia Therapeutics Inc | Polinucleótidos, composiciones y métodos para la expresión de polipéptidos. |
| CN114127044A (zh) | 2019-04-25 | 2022-03-01 | 英特利亚治疗股份有限公司 | 可电离的胺类脂质和脂质纳米颗粒 |
| AR124555A1 (es) * | 2019-06-11 | 2023-04-12 | Pairwise Plants Services Inc | Métodos para producir plantas con desarrollo de frutas alteradas y plantas derivas de las mismas |
| EP4028063A1 (en) * | 2019-09-13 | 2022-07-20 | Regeneron Pharmaceuticals, Inc. | Transcription modulation in animals using crispr/cas systems delivered by lipid nanoparticles |
| IL303506A (en) * | 2020-12-11 | 2023-08-01 | Intellia Therapeutics Inc | Polynucleotides, compositions, and methods for genome editing involving deamination |
-
2022
- 2022-11-02 CA CA3237303A patent/CA3237303A1/en active Pending
- 2022-11-02 MX MX2024005242A patent/MX2024005242A/es unknown
- 2022-11-02 TW TW111141875A patent/TW202325848A/zh unknown
- 2022-11-02 EP EP22826533.6A patent/EP4426822A2/en active Pending
- 2022-11-02 JP JP2024525233A patent/JP2024542995A/ja active Pending
- 2022-11-02 AU AU2022382975A patent/AU2022382975A1/en active Pending
- 2022-11-02 KR KR1020247018182A patent/KR20240114296A/ko active Pending
- 2022-11-02 IL IL312508A patent/IL312508A/en unknown
- 2022-11-02 WO PCT/US2022/079124 patent/WO2023081689A2/en not_active Ceased
-
2024
- 2024-04-30 CL CL2024001332A patent/CL2024001332A1/es unknown
- 2024-05-01 US US18/652,180 patent/US20240301377A1/en active Pending
- 2024-05-31 CO CONC2024/0007019A patent/CO2024007019A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024542995A5 (enExample) | ||
| Haffar et al. | The matrix protein gene sequence analysis reveals close relationship between peste des petits ruminants virus (PPRV) and dolphin morbillivirus | |
| JP2024525665A5 (enExample) | ||
| Schütze et al. | Complete genomic sequence of the fish rhabdovirus infectious haematopoietic necrosis virus | |
| JP2023553935A5 (enExample) | ||
| Mundt et al. | Complete nucleotide sequences of 5′-and 3′-noncoding regions of both genome segments of different strains of infectious bursal disease virus | |
| Chad et al. | Sequence conservation and divergence of hepatitis δ virus RNA | |
| Lapps et al. | Sequence analysis of the bovine coronavirus nucleocapsid and matrix protein genes | |
| Peeters et al. | Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence | |
| JP2021534798A5 (enExample) | ||
| JP2019536425A5 (enExample) | ||
| Jeong et al. | Characterization of the DNA nucleotide sequences in the genome of red sea bream iridoviruses isolated in Korea | |
| JP2024520528A5 (enExample) | ||
| JP2024511163A5 (enExample) | ||
| JPS62163693A (ja) | ニユ−カツスル病ウイルス遺伝子クロ−ン | |
| Jeeva et al. | Crimean-Congo hemorrhagic fever virus nucleocapsid protein augments mRNA translation | |
| JP2024511131A5 (enExample) | ||
| Agrawal et al. | Sequence and analysis of the capsid protein of Nudaurelia capensis ω virus, an insect virus with T= 4 icosahedral symmetry | |
| Zou et al. | Complete genome sequence and biological characterizations of a novel goose paramyxovirus-SF02 isolated in China | |
| Li et al. | Sequence and insertion sites of murine melanoma-associated retrovirus | |
| Hwang et al. | Expression of functional influenza virus RNA polymerase in the methylotrophic yeast Pichia pastoris | |
| JP2023529844A5 (enExample) | ||
| Almeida-Pinto et al. | Navigating the complex landscape of ebola infection treatment: A review of emerging pharmacological approaches | |
| JP2024518413A5 (enExample) | ||
| Ling et al. | Sequence and in vitro expression of the phosphoprotein gene of avian pneumovirus |